诺华地拉罗司价格

(Deferasirox) is an N-substituted bishydroxyphenyltriazole, a new tridentate oral iron chelator used to treat transfusion-induced iron overload. A large number of preclinical and clinical studies have shown that deferasirox is well tolerated and has the effect of mobilizing tissue iron and promoting iron excretion. The drug has been marketed in more than 85 countries including the United States, the European Union and China. The plasma half-life of deferasirox is 8 to 16 hours, and its stable plasma concentration ensures that patients can receive reliable iron-removing treatment; the simple once-daily oral administration greatly solves the problem of poor compliance with deferoxamine treatment, and can be accepted by the vast majority of patients, ensuring long-term iron-removing treatment.

According to Medical Companion Travel, Novartis deferasirox is very cheap abroad, with a price of about 400$ for a 400mg*30 tablet/box. Domestic patients in need can, on the one hand, go abroad to purchase the required drugs in person, or on the other hand, contact some professional and formal domestic overseas medical service institutions (such as Medical Companion Travel) to obtain their specific drug purchase channels.

Deferasirox has good safety and tolerability. Only some patients in the study experienced an increase in liver transaminases (ALT <10 times the upper limit of the normal reference value) and a transient mild increase in Cr; no serious gastrointestinal reactions and rashes were found, and there were no serious adverse reactions such as cytopenias, optic nerve damage, or ototoxicity. No patient stopped treatment due to serious adverse events, and there were no deaths.

Swiss Novartis AG is the world leader in pharmaceutical manufacturing and health care product consumption. It is a multinational company established in 1996. It was formed by the merger of two Swiss companies with a long history - Ciba-Geigy and Sandoz. The quality of the products produced by it is guaranteed, and patients can buy with confidence. When it comes to actual purchase, patients can purchase medicines domestically or overseas through medical companion travel, which will be more cost-effective.

Recommended hot articles: /newsDetail/92211.html